Refine by
Sclerosis Disease Articles & Analysis: Older
8 news found
Institut Guttmann (Badalona); Heidelberg University Hospital (Heidelberg), Asepeyo Hospital (Sant Cugat); CEN (European Center of Neurosciences) (Madrid); Vall d’Hebron Hospital (Barcelona); SIRN (Barcelona); Isidre Esteve Foundation (Sant Cugat); National Hospital for Paraplegics (Toledo); Association of Multiple Sclerosis and other neurological diseases ...
Strengthened by this positive news and our constructive dialogue with the FDA, we continue working towards the goal of being able to offer an effective and safe treatment for patients with systemic sclerosis," says Patric Stenberg, CEO of Gesynta Pharma. Systemic sclerosis (also known as scleroderma) is a chronic, autoimmune disease that ...
Qynapse will demo its flagship FDA-cleared and CE-marked neuroimaging solution, QyScore®, which combines MRI scans and AI to produce rapid, actionable insights into CNS disorders, such as Alzheimer’s disease, multiple sclerosis and Parkinson’s disease. “This year’s event represents a turning point in our product ...
ByQynapse
These adult and pediatric patients have chronic respiratory insufficiency due to conditions such as high spinal cord injuries (SCI), Congenital Hypoventilation Syndrome (CCHS), Central Sleep Apnea, Acute Flaccid Myelitis (AFM), various central neurological disorders, autoimmune diseases including Multiple Sclerosis and diseases caused by insect ...
Haymarket Medical Network today launched Rare Disease Advisor, a new digital resource for healthcare professionals (HCPs) to help them recognize, diagnose, refer and treat rare diseases. ...
Coordinating Investigator Professor Ariane Herrick, The University of Manchester Centre for Musculoskeletal Research commented: "Systemic sclerosis is a chronic, autoimmune disease that leads to serious damage to the microvessels and which is associated with great unmet need. ...
Gesynta Pharma AB today announced that the first patients have been dosed in a Phase II study of its oral drug candidate GS-248 in patients with systemic sclerosis - a debilitating autoimmune disease that causes serious damage to the microvasculature. ...
Researchers at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, (www.saneron-ccel.com) and the University of South Florida have received a patent relating to a method for obtaining and using umbilical cord blood cells from a donor or patient to provide neural cells for transplantation aimed at repairing a variety of neurodegenerative diseases of the brain and spinal cord, such ...